Zobrazeno 31 - 40
of 197
pro vyhledávání: '"Burris, Howard A 3rd"'
Autor:
Burris HA 3rd; Sarah Cannon Research Institute, Nashville, TN.
Publikováno v:
HCA healthcare journal of medicine [HCA Healthc J Med] 2020 Nov 28; Vol. 1, pp. 321-323. Date of Electronic Publication: 2020 Nov 28 (Print Publication: 2020).
Autor:
Voss MH; Department of Medicine, 300 East 66th Street, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. vossm@mskcc.org., Gordon MS; Oncology Research, HonorHealth Research Institute, 10510 N 92nd St Suite 200, Scottsdale, AZ, 85258, USA., Mita M; Department of Hematology and Oncology, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, 8700 Beverly Blvd North Tower, Los Angeles, CA, 90048, USA., Rini B; Cleveland Clinic Foundation, Department of Solid Tumor Oncology, 9500 Euclid Avenue, Cleveland, OH, 44195, USA., Makker V; Department of Medicine, 300 East 66th Street, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Macarulla T; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Passeig de la Vall d'Hebron, 119, 129, 08035, Barcelona, Spain., Smith DC; University of Michigan, Department of Internal Medicine, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109, USA., Cervantes A; CIBERONC, Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Avda. Menéndez Pelayo 4 acc., 46010, Valencia, Spain., Puzanov I; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology/Oncology, 1161 21st Ave S, Nashville, TN, 37232, USA.; Clovis Oncology, San Francisco, CA, USA., Pili R; Indiana University-Simon Cancer Center, Department of Medicine, Division of Hematology/Oncology, 535 Barnhill Drive, Indianapolis, IN, 46202, USA., Wang D; Henry Ford Health System, Hematology/Oncology, 1 Ford Pl, Detroit, MI, 48202, USA., Jalal S; Indiana University Melvin and Bren Simon Cancer Center, Hematology/Oncology, 535 Barnhill Drive, Indianapolis, IN, 46202, USA., Pant S; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA., Patel MR; Florida Cancer Specialists/SCRI, Drug Development Unit, 600 N Cattlemen Rd #200, Sarasota, FL, 34232, USA., Neuwirth RL; Biostatistics, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Enke A; Oncology Clinical Research, Millennium Pharmaceuticals Inc., 40 Landsdowne Street, Cambridge, MA, 02139, USA.; Clovis Oncology, San Francisco, CA, USA., Shou Y; Oncology Clinical Research, Millennium Pharmaceuticals Inc., 40 Landsdowne Street, Cambridge, MA, 02139, USA.; Trillium Therapeutics Inc., Cambridge, MA, USA., Sedarati F; Oncology Clinical Research, Millennium Pharmaceuticals Inc., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Faller DV; Oncology Clinical Research, Millennium Pharmaceuticals Inc., 40 Landsdowne Street, Cambridge, MA, 02139, USA., Burris HA 3rd; Sarah Cannon Research Institute/Tennessee Oncology, Drug Development Unit, 250 25th Ave., North Nashville, TN, 37203, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2020 Nov; Vol. 123 (11), pp. 1590-1598. Date of Electronic Publication: 2020 Sep 11.
Autor:
Gordon LI; Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois. l-gordon@northwestern.edu., Kaplan JB; Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois., Popat R; NIHR/UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Burris HA 3rd; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee., Ferrari S; Ospedale Papa Giovanni XXIII, Bergamo, Italy., Madan S; Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, Texas., Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida., Gritti G; Ospedale Papa Giovanni XXIII, Bergamo, Italy., El-Sharkawi D; NIHR/UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Chau I; Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Radford JA; The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom., Pérez de Oteyza J; Hospital Universitario Madrid Sanchinarro, Universidad CEU San Pablo, Madrid, Spain., Zinzani PL; Institute of Hematology 'Seragnoli,' University of Bologna, Bologna, Italy., Iyer S; Houston Methodist Cancer Center, Houston, Texas., Townsend W; NIHR/UCLH Clinical Research Facility, University College London Hospitals NHS Foundation Trust, London, United Kingdom., Karmali R; Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois., Miao H; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Proscurshim I; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Wang S; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Wu Y; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Stumpo K; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Shou Y; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Carpio C; University Hospital Vall d'Hebron, Barcelona, Spain., Bosch F; University Hospital Vall d'Hebron, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 15; Vol. 26 (14), pp. 3546-3556. Date of Electronic Publication: 2020 Apr 23.
Autor:
Yardley DA; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN. Electronic address: dyardley@tnonc.com., Liggett W; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN., Mainwaring M; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN., Castrellon A; Memorial Cancer Institute, Hollywood, FL., Blakely L; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN., Hemphill B; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN., Anz B 3rd; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN., Young RR; The Center for Cancer and Blood Disorders, Fort Worth, TX., Shastry M; Sarah Cannon Research Institute, Nashville, TN., DeBusk LM; Sarah Cannon Research Institute, Nashville, TN., Hainsworth JD; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, PLLC, Nashville, TN.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2020 Apr; Vol. 20 (2), pp. 89-97. Date of Electronic Publication: 2019 Jun 26.
Autor:
Burris HA 3rd; Sarah Cannon Research Institute, Nashville, TN, USA. Howard.Burris@SarahCannon.com.; The American Society of Clinical Oncology, Alexandria, VA, USA. Howard.Burris@SarahCannon.com.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2020 Feb; Vol. 17 (2), pp. 125.
Autor:
Gerber DE; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Infante JR; Janssen Pharmaceuticals, Inc., Raritan, New Jersey., Gordon MS; HonorHealth Research Institute, Scottsdale, Arizona., Goldberg SB; Yale School of Medicine, New Haven, Connecticut., Martín M; Instituto De Investigacion Sanitaria Gregorio Marañon, Ciberonc, Universidad Complutense, Madrid, Spain., Felip E; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Martinez Garcia M; Hospital del Mar, Barcelona, Spain., Schiller JH; Inova Fairfax Hospital, Annandale, Virginia., Spigel DR; Sarah Cannon Research Institute, Nashville, Tennessee., Cordova J; Genentech, Inc., South San Francisco, California., Westcott V; Genentech, Inc., South San Francisco, California., Wang Y; Genentech, Inc., South San Francisco, California., Shames DS; Genentech, Inc., South San Francisco, California., Choi Y; Genentech, Inc., South San Francisco, California., Kahn R; Genentech, Inc., South San Francisco, California., Dere RC; Genentech, Inc., South San Francisco, California., Samineni D; Genentech, Inc., South San Francisco, California., Xu J; Genentech, Inc., South San Francisco, California., Lin K; Genentech, Inc., South San Francisco, California., Wood K; Genentech, Inc., South San Francisco, California., Royer-Joo S; Genentech, Inc., South San Francisco, California., Lemahieu V; Genentech, Inc., South San Francisco, California., Schuth E; Genentech, Inc., South San Francisco, California., Vaze A; Genentech, Inc., South San Francisco, California., Maslyar D; Genentech, Inc., South San Francisco, California., Humke EW; Genentech, Inc., South San Francisco, California., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee. howard.burris@SarahCannon.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jan 15; Vol. 26 (2), pp. 364-372. Date of Electronic Publication: 2019 Sep 20.
Autor:
Spigel DR; Sarah Cannon Research Institute, Nashville, Tennessee, USA dspigel@tnonc.com.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Shipley DL; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Waterhouse DM; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA., Jones SF; Sarah Cannon Research Institute, Nashville, Tennessee, USA., Ward PJ; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Oncology Hematology Care, Cincinnati, Ohio, USA., Shih KC; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Hemphill B; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., McCleod M; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Ft. Myers Florida, USA., Whorf RC; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Florida Cancer Specialists, Bradenton, Florida, USA., Page RD; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Center for Cancer and Blood Disorders, Ft. Worth, Texas, USA., Stilwill J; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Research Medical Center, Kansas City, Missouri, USA., Mekhail T; Florida Hospital Cancer Institute, Orlando, Florida, USA., Jacobs C; Oncogenex, Bothell, Washington, USA., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA., Hainsworth JD; Sarah Cannon Research Institute, Nashville, Tennessee, USA.; Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
Publikováno v:
The oncologist [Oncologist] 2019 Dec; Vol. 24 (12), pp. e1409-e1416. Date of Electronic Publication: 2019 Aug 16.
Autor:
Garrido-Laguna I; Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Krop I; Department of Medical Oncology, Dana-Farber Cancer Center/Brigham and Women's Hospital, Boston, MA., Burris HA 3rd; Department of Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN., Hamilton E; Department of Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN., Braiteh F; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada and University of Nevada Las Vegas School of Medicine, Las Vegas, NV., Weise AM; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI., Abu-Khalaf M; Department of Breast Medical Oncology, Thomas Jefferson University, Philadelphia, PA., Werner TL; Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Pirie-Shepherd S; Pfizer Inc., Oncology, San Diego, CA., Zopf CJ; Pfizer Inc., Oncology, San Diego, CA., Lakshminarayanan M; Pfizer Inc., Oncology, San Diego, CA., Holland JS; Pfizer Inc., Oncology, San Diego, CA., Baffa R; Pfizer Inc., Oncology, San Diego, CA., Hong DS; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX.
Publikováno v:
International journal of cancer [Int J Cancer] 2019 Oct 01; Vol. 145 (7), pp. 1798-1808. Date of Electronic Publication: 2019 Feb 23.
Autor:
Kovacs RJ, Burris HA 3rd
Publikováno v:
JACC. CardioOncology [JACC CardioOncol] 2019 Sep 24; Vol. 1 (1), pp. 133-134. Date of Electronic Publication: 2019 Sep 24 (Print Publication: 2019).
Autor:
Hainsworth JD; Tennessee Oncology PLLC, 4220 Harding Road, Ste. 200, Nashville, TN, 37205, USA., Becker KP; Yale University, New Haven, CT, USA., Mekhail T; Florida Cancer Specialists/SCRI, Ft. Myers, FL, USA., Chowdhary SA; Florida Cancer Specialists/SCRI, Ft. Myers, FL, USA., Eakle JF; Florida Cancer Specialists/SCRI, Ft. Myers, FL, USA., Wright D; Florida Cancer Specialists/SCRI, Ft. Myers, FL, USA., Langdon RM; Nebraska Methodist Cancer Center, Omaha, NE, USA., Yost KJ; Grand Rapids Oncology Program, Grand Rapids, MI, USA., Padula GDA; Grand Rapids Oncology Program, Grand Rapids, MI, USA., West-Osterfield K; Sarah Cannon, Nashville, TN, USA., Scarberry M; Sarah Cannon, Nashville, TN, USA., Shaifer CA; Sarah Cannon, Nashville, TN, USA., Shastry M; Sarah Cannon, Nashville, TN, USA., Burris HA 3rd; Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, TN, USA., Shih K; Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, TN, USA. kshih@tnonc.com.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2019 Sep; Vol. 144 (2), pp. 303-311. Date of Electronic Publication: 2019 Aug 07.